Pega Named a Leader in AI Decisioning Platforms by Independent Research Firm
Pega's AI-powered decisioning and workflow automation capabilities recognized with highest scores possible in all strategy criteria
WALTHAM, Mass., June 10, 2025--(BUSINESS WIRE)--Pegasystems Inc. (NASDAQ: PEGA), The Enterprise Transformation CompanyTM, today announced Forrester Research has named Pega a Leader in The Forrester Wave™: AI Decisioning Platforms, Q2 2025 (1). Pega earned the highest score in the strategy category, including the highest scores possible in the vision, innovation, roadmap, partner ecosystem, adoption, and supporting services and offerings criteria.
The report states: "Pega's approach is timeless — it aims to build a platform that enables enterprises to 'design for people, build for change.' The company is now using AI to do that, infusing it into every platform capability, including Pega GenAI BlueprintTM, which enables users to generate full decisioning workflows and build AI agents using natural language. Pega is firing on all cylinders with its superior vision, innovation, roadmap, partner ecosystem, adoption, and support services."
On Pega's platform capabilities, the report states: "Pegasystems' platform excels in data modeling and integration, enabling enterprises to effectively create a simplified data abstraction layer for decisioning applications. Governance capabilities, including lifecycle management and observability, facilitate compliance and mission-critical monitoring. The platform's extensible architecture enables customers to integrate with enterprise systems and offers an on-ramp to Pegasystems' partners to add industry-specific modules."
The report also found that reference customers report "implementing the Pega platform broke down customer data silos, unified processes, and most importantly, enabled hyper-personalization for millions of consumers," noting that "Pega turns executives into customer-centric heroes."
This Forrester Wave report evaluated 15 vendors across 18 criteria spanning current offering, strategy, and also customer feedback. Pega received the highest scores possible for the following criteria: data modeling, data integration, decision testing, cohesive experience, lifecycle, observability, and extensibility.
Forrester evaluated Pega InfinityTM, Pega's suite of solutions for AI-powered decisioning and workflow automation, including Pega PlatformTM, a powerful low-code platform combining AI-powered decisioning and workflow automation to help enterprises efficiently build scalable, intelligent apps. It also analyzed Pega Customer Decision HubTM, an AI-powered, real-time decisioning engine that delivers hyper-personalized next-best-actions to optimize customer engagement. Additionally, the evaluation recognized Pega Blueprint, Pega's genAI-powered design agent that transforms client goals and documentation into modern, agent-driven app workflows using Pega's best practices. These tools provide a comprehensive approach to AI decisioning for Pega clients to achieve measurable, optimized business outcomes.
This report is among Pega's many recent analyst recognitions for its customer engagement, enterprise AI, and workflow automation capabilities. Recently, Pega was recognized as a Leader in the Gartner® Magic Quadrant for Process Mining Platforms 2025 (2), Gartner® Magic Quadrant for CRM Customer Engagement Center (CEC) 2024 (3), and the Gartner® Magic Quadrant™ for Enterprise Low-code Application Platforms (LCAP) (4). It was also named a Leader in The Forrester WaveTM: Customer Relationship Management Software, Q1 2025 (5), The Forrester Wave: Real-Time Interaction Management, Q1 2024 (6), The Forrester WaveTM: Customer Service Solutions 2024 (7), and The Forrester WaveTM: Task-Centric Automation Software, Q4 2024 (8). For more background on these and additional analyst reports, visit www.pega.com/analyst-reports.
Quotes & Commentary:"Today's organizations need precise, adaptive AI that empowers both humans and AI agents to make fast, context-aware decisions," said Kerim Akgonul, chief product officer, Pega. "Pega's AI decisioning capabilities are designed as a surgical, statistical engine that continuously learns and optimizes workflows—whether it's guiding a customer interaction or automating a process. This recognition reinforces our commitment to delivering the right AI for the right purpose, enabling our clients to build self-optimizing systems that drive meaningful, transformational outcomes."
Supporting Resources:
Report access: The Forrester Wave™: AI Decisioning Platforms, Q2 2025
Solution background: Pega Infinity
Solution background: Pega Blueprint
Solution background: Pega Customer Decision Hub
Solution background: Pega Platform
Forrester Research, "The Forrester Wave™: AI Decisioning Platforms, Q2 2025," by Mike Gualtieri with contributions from Sudha Maheshwari, Bardia Razzaghi, and Jen Barton, June 10, 2025
Gartner, Inc., "Magic Quadrant for Process Mining Platforms, Q1, 2025," by Tushar Srivastava, Marc Kerremans, David Sugden, April 16, 2025
Gartner, Inc., "Magic Quadrant for the CRM Customer Engagement Center (CEC) 2024," by Pri Rathnayake, Wynn White, Drew Kraus, December 2024
Gartner, Inc., "Magic Quadrant for Enterprise Low-Code Application Platforms," by Oleksandr Matviskyy, Kyle Davis, and Akash Jain, October 16, 2024
Forrester Research, "The Forrester Wave™: Customer Relationship Management Software, Q1 2025," by Kate Leggett, with contributions from Linda Ivy-Rosser and Faith Born, March 21, 2025
Forrester Research, "The Forrester Wave™: Real-Time Interaction Management, Q1 2024" by Rusty Warner, February 26, 2024
Forrester Research, "The Forrester Wave™: Customer Service Solutions, Q1 2024" by Kate Leggett, March 6, 2024
Forrester Research, "The Forrester Wave™: Task-Centric Automation Software, Q4 2024" by Bernhard Schaffrik, Pascal Matzke, Faith Born, and Kara Hartig
Forrester does not endorse any company, product, brand, or service included in its research publications and does not advise any person to select the products or services of any company or brand based on the ratings included in such publications. Information is based on the best available resources. Opinions reflect judgment at the time and are subject to change. For more information, read about Forrester's objectivity here.
About PegasystemsPega is The Enterprise Transformation CompanyTM that helps organizations Build for Change® with enterprise AI decisioning and workflow automation. Many of the world's most influential businesses rely on our platform to solve their most pressing challenges, from personalizing engagement to automating service to streamlining operations. Since 1983, we've built our scalable and flexible architecture to help enterprises meet today's customer demands while continuously transforming for tomorrow. For more information on Pega (NASDAQ: PEGA), visit www.pega.com.
All trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610448876/en/
Contacts
Press Contact: Ilena RyanPegasystemsilena.ryan@pega.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
25 minutes ago
- Business Wire
Coeur to Participate in the RBC Capital Markets Global Mining & Materials Conference
CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc.'s ('Coeur' or the 'Company') (NYSE: CDE) Chairman, President and Chief Executive Officer, Mitchell J. Krebs, and Senior Vice President and Chief Financial Officer, Thomas S. Whelan, will participate in the RBC Capital Markets Global Mining & Materials Conference in New York, New York on Thursday, June 12, 2025. The RBC Capital Markets Global Mining & Materials Conference is an invitation-only investment conference. Presentation materials will be made available on the Company's website at About Coeur Coeur Mining, Inc. is a U.S.-based, well-diversified, growing precious metals producer with five wholly-owned operations: the Las Chispas silver-gold mine in Sonora, Mexico, the Palmarejo gold-silver complex in Chihuahua, Mexico, the Rochester silver-gold mine in Nevada, the Kensington gold mine in Alaska and the Wharf gold mine in South Dakota. In addition, the Company wholly-owns the Silvertip polymetallic critical minerals exploration project in British Columbia.


Business Wire
25 minutes ago
- Business Wire
CFP Board Convenes AI Working Group
WASHINGTON--(BUSINESS WIRE)--CFP Board is convening an AI Working Group on June 10-11 at its Washington, D.C., headquarters to explore how artificial intelligence is transforming the financial planning ecosystem and to define the evolving role of human expertise in a tech-powered future. As part of CFP Board's broader strategy to help the profession thrive in an AI-powered world, the group is developing strategic, actionable recommendations to guide the profession forward, helping ensure that technology enhances the human relationships at the core of financial planning. 'AI is not a distant wave. It's already reshaping client expectations and how advisors deliver value,' said CFP Board CEO Kevin R. Keller, CAE. 'CFP Board is taking the lead to help the profession harness AI's potential to elevate financial planning and strengthen engagement.' In partnership with consulting company Heidrick & Struggles and led by CFP Board COO K. Dane Snowden, the AI Working Group brings together financial and technology leaders to explore how the financial planning profession can rise to meet the challenges and opportunities of an AI-driven future. The group is examining emerging trends, real-world use cases and ethical considerations shaping AI adoption across the profession. From enhancing client experiences and streamlining advisor workflows to protecting public trust, the conversations reflect both the complexity and the promise of this pivotal moment. Discussion topics include the Current State of AI, Regulation and The Financial Planner Lens, as well as exercises on exploring future scenarios and evaluating key stakeholder implications. The AI Working Group includes the following members: Andrew Altfest, CFP ®, MBA, Founder and CEO, FP Alpha and President, Altfest Personal Wealth Management Joel Bruckenstein, CFP ®, CMFC, CFS, President, T3 Technology Alan Davidson, former Assistant Secretary of Commerce and Administrator, National Telecommunications and Information Administration Tristan Fischer, Managing Director, Financial Services Consulting, Ernst & Young LLP Tim Foley, Head of Artificial Intelligence Accelerator, LPL Financial David Goldberg, Senior Vice President, Chief Data and Analytics Officer, Edelman Financial Engines Brooke Juniper, CFA ®, CAIA ®, Chief Executive Officer, Sage Trent Mumma, Chief Product Officer, Orion Advisor Solutions Celeste Revelli, CFP ®, BFA ™, CSM ®, CSPO ®, Vice President of Financial Planning Technology, Fidelity Institutional ® (FI) Noah Rosenberg, Chief Financial Officer, Morning Consult Apoorv Saxena, Managing Director, Head of AI/Data Driven Value Creation, Silver Lake Megan Shearer, Ph.D., Senior Data Scientist, Janus Henderson Zar Toolan, General Partner, Head of Data & AI, Edward Jones Brian Walsh, Ph.D., CFP ®, Head of Advice & Planning, SoFi For more information on using AI in financial planning, download CFP Board's Generative AI Ethics Guide, which provides a framework for CFP ® professionals to integrate AI into their practices ethically. ABOUT CFP BOARD CFP Board is the professional body for personal financial planners in the U.S. CFP Board consists of two affiliated organizations focused on advancing the financial planning profession for the public's benefit. CFP Board of Standards sets and upholds standards for financial planning and administers the prestigious CERTIFIED FINANCIAL PLANNER ® certification — widely recognized by the public, advisors and firms as the standard for financial planners — so that the public has access to the benefits of competent and ethical financial planning. CFP ® certification is held by more than 100,000 people in the U.S. CFP Board Center for Financial Planning addresses diversity and workforce development challenges and conducts and publishes research that adds to the financial planning profession's body of knowledge.


Business Wire
27 minutes ago
- Business Wire
Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) ('Simulations Plus' or the 'Company'), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary revenue for its third fiscal quarter and updated its full year 2025 revenue guidance. The Company expects to report third quarter fiscal 2025 revenue in the range of between $19 million and $20 million Full year fiscal 2025 revenue is expected to range between $76 million and $80 million The third quarter fiscal 2025 revenue range set forth above is preliminary, unaudited, based on currently available information, and subject to adjustment in the final financial statements to be filed with the Company's Quarterly Report on Form 10-Q for the third quarter fiscal 2025, expected to be filed July 2, 2025. Full year fiscal 2025 revenue guidance may also be adjusted when the Company reports third quarter fiscal 2025 results. 'Market uncertainties surrounding future funding, drug pricing and potential tariffs are creating significant headwinds for both our pharmaceutical and biotech clients, resulting in budget reductions, project cancellations, and delays that are more pronounced than what we have experienced over the past two years,' said Shawn O'Connor, Chief Executive Officer of Simulations Plus. 'While our software segment has remained relatively resilient, given its role as critical infrastructure in drug development programs, demand for services has proven more sensitive to market volatility and is coming in below our expectations. 'To better position the Company for long-term alignment with our clients, we recently announced a strategic reorganization—transitioning from a business unit structure to a functionally driven operating model. We also made key leadership appointments to enhance client engagement and elevate our sales and marketing capabilities. 'These actions mark the final phase of a multi-year transformation aimed at streamlining operations, unlocking synergies across teams, and concentrating our resources on the most promising growth opportunities. We believe the new organizational structure will also foster greater collaboration through centralized product and technology development, contributing to accelerated delivery of software enhancements, platform integration, and AI advancements. 'Finally, these changes are expected to improve operational efficiency and better position us for sustainable and profitable long-term growth. Looking ahead, we remain optimistic about the future of predictive analytics in biosimulation and clinical operations. These capabilities are essential to helping our clients achieve greater efficiency and success, and we are proud to be a long-standing partner and innovation leader in this space,' concluded O'Connor. Third Quarter Fiscal 2025 Press Release, Webcast, and Conference Call Details The Company will report third quarter fiscal 2025 financial results after the market close on Wednesday, July 2, 2025. Shawn O'Connor, Chief Executive Officer, and Will Frederick, Chief Financial Officer, will host a conference call and webcast on the same day at 5:00 p.m. Eastern Time to discuss the details of Simulations Plus' performance for the quarter and certain forward-looking information. The call may be accessed by registering here or by calling 1-877-451-6152 (domestic) or 1-201-389-0879 (international). The webcast can be accessed on the investor relations page of the Simulations Plus website where it will also be available for replay approximately one hour following the call. About Simulations Plus, Inc. With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at Follow us on LinkedIn | X | YouTube. Environmental, Social, and Governance (ESG) We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2024 ESG update. Preliminary Financial Results and Financial Guidance The preliminary financial results set forth above for the third quarter fiscal 2025 reflect preliminary, unaudited estimates with respect to such results based solely on currently available information, which is subject to change. Such preliminary results are subject to the finalization of quarter-end financial and accounting procedures. While carrying out such procedures, Simulations Plus may identify items that would require it to make adjustments to the preliminary estimates of financial results set forth herein. As a result, our actual financial results could differ than the information set forth herein and such differences could be material. Preliminary results should not be viewed as a substitute for our full quarterly financial statements for the three months ended May 31, 2025, which are being prepared in accordance with U.S. GAAP. In addition, full year fiscal 2025 revenue guidance should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. Forward-Looking Statements Except for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like 'believe,' 'will', 'can', 'believe', 'expect,' 'anticipate' and similar expressions (or the negative of such terms, as well as other words or expressions referencing future events, conditions or circumstances) mean that these are our best estimates as of this writing, but there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Forward looking statements contained in this press release include, but are not limited to, the quotation of our Chief Executive Officer relating to our future performance and growth, statements relating to full fiscal year 2025 revenue guidance and other statements about future events. Factors that could cause or contribute to such differences include, but are not limited to: effectiveness of our new operational structure our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, market conditions, macroeconomic factors, and a sustainable market. Further information on our risk factors is contained in our quarterly, annual and current reports and filed with the U.S. Securities and Exchange Commission.